Found: 21
Select item for more details and to access through your institution.
Health outcomes in spinal muscular atrophy type 1 following AVXS‐101 gene replacement therapy.
- Published in:
- Pediatric Pulmonology, 2019, v. 54, n. 2, p. 179, doi. 10.1002/ppul.24203
- By:
- Publication type:
- Article
Socio economic crisis and mortality. Epidemiological testimony of the financial collapse of Argentina.
- Published in:
- Thrombosis Journal, 2005, v. 3, p. 22, doi. 10.1186/1477-9560-3-22
- By:
- Publication type:
- Article
An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and Effectiveness Review (ICER).
- Published in:
- Journal of Market Access & Health Policy, 2021, v. 9, n. 1, p. 1, doi. 10.1080/20016689.2021.1889841
- By:
- Publication type:
- Article
Economic burden of spinal muscular atrophy: an analysis of claims data.
- Published in:
- Journal of Market Access & Health Policy, 2020, v. 8, n. 1, p. 1, doi. 10.1080/20016689.2020.1843277
- By:
- Publication type:
- Article
Health economic evaluation of gene replacement therapies: methodological issues and recommendations.
- Published in:
- Journal of Market Access & Health Policy, 2020, v. 8, n. 1, p. 1, doi. 10.1080/20016689.2020.1822666
- By:
- Publication type:
- Article
Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients.
- Published in:
- Journal of Market Access & Health Policy, 2019, v. 7, n. 1, p. 1, doi. 10.1080/20016689.2019.1601484
- By:
- Publication type:
- Article
Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.
- Published in:
- European Heart Journal, 2005, v. 26, n. 11, p. 1063, doi. 10.1093/eurheartj/ehi139
- By:
- Publication type:
- Article
From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes.
- Published in:
- European Heart Journal, 2003, v. 24, n. 15, p. 1414, doi. 10.1016/S0195-668X(03)00315-4
- By:
- Publication type:
- Article
A Validated Prediction Model for All Forms of Acute Coronary Syndrome: Estimating the Risk of 6-Month Postdischarge Death in an International Registry.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 291, n. 22, p. 2727, doi. 10.1001/jama.291.22.2727
- By:
- Publication type:
- Article
Hyperuricemia in Young Adults and Risk of Insulin Resistance, Prediabetes, and Diabetes: A 15-Year Follow-up Study.
- Published in:
- American Journal of Epidemiology, 2012, v. 176, n. 2, p. 108, doi. 10.1093/aje/kws002
- By:
- Publication type:
- Article
Treatment preferences in spinal muscular atrophy: A swing weighting study for caregivers of patients with SMA types 1 and 2.
- Published in:
- PLoS ONE, 2024, v. 19, n. 10, p. 1, doi. 10.1371/journal.pone.0309666
- By:
- Publication type:
- Article
Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey.
- Published in:
- 2011
- By:
- Publication type:
- journal article
GERD-related health care utilization, therapy, and reasons for transfer of GERD patients between primary care providers and gastroenterologists in a US managed care setting.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Patient and Caregiver Outcomes After Onasemnogene Abeparvovec Treatment: Findings from the Cure SMA 2021 Membership Survey.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 12, p. 5315, doi. 10.1007/s12325-023-02685-w
- By:
- Publication type:
- Article
Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 10, p. 4589, doi. 10.1007/s12325-023-02621-y
- By:
- Publication type:
- Article
Valuation of Treatments for Rare Diseases: A Systematic Literature Review of Societal Preference Studies.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 2, p. 393, doi. 10.1007/s12325-022-02359-z
- By:
- Publication type:
- Article
Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 5, p. 1915, doi. 10.1007/s12325-022-02089-2
- By:
- Publication type:
- Article
Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 12, p. 5809, doi. 10.1007/s12325-021-01938-w
- By:
- Publication type:
- Article
Response to: Alfred Sandrock, Wildon Farwell. Letter to the Editor, Comparisons Between Separately Conducted Clinical Trials: Letter to the Editor Regarding Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Guérin A, et al. Adv Ther (2019) 36(5):1164-76. doi:10.1007/s12325-019-00923-8.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Chronic kidney disease in gout in a managed care setting.
- Published in:
- 2011
- By:
- Publication type:
- journal article